60
Views
5
CrossRef citations to date
0
Altmetric
ARTICLE

Repeat Percutaneous Radiofrequency Facet Joint Denervation for Chronic Back Pain: A Prospective Study

, MBBS (Hons) & , MD, PhD, FRACS, FAOrthA
Pages 153-158 | Accepted 17 Mar 2009, Published online: 13 May 2010
 

ABSTRACT

Objective: To investigate whether repeat lumbar percutaneous radiofrequency facet joint denervation [RFJD] is an efficacious ongoing treatment for chronic low back pain [LBP] using the Low Back Outcome Score [LBOS] and subjective measures of patient satisfaction.

Methods: A prospective open-label, single intervention study was carried out on a consecutive series of patients undergoing repeat lumbar RFJD performed by a single operator in 2007. Patients with an initially successful RFJD procedure were selected for the study excluding patients with greater than four procedures in total. Lumbar medial branch neurotomy was conducted using a 20-gauge silicone-coated probe inserted under fluoroscopic control and neuroleptic intravenous sedation with radiofrequency thermal energy applied for 90 seconds per joint at a maximum probe tip temperature of 90°C. The patients completed a LBOS questionnaire before and 12 months following the repeat RFJD procedure. They were also asked about their satisfaction with and the duration of pain relief related to their repeat procedure.

Results: Sixty-two patients completed the study. At 12-month follow-up, clinical outcomes were improved with the proportion of patients with poor rating according to LBOS decreasing from 69.4 percent pre-procedure to 41.9 percent after repeat RFJD [P < 0.01]. Overall, 69.3 percent of patients were satisfied with the procedure with a median average duration of eight to nine months for pain relief. There were no complications in this series.

Conclusion: Repeat lumbar RFJD, in this cohort of appropriately selected patients, achieved a high level of satisfaction and improved LBOS score, and may be a valid option for ongoing treatment for patients with chronic LBP. It would appear that a blinded, randomized, sham treatment-controlled clinical trial would be warranted.

ACKNOWLEDGEMENTS

The authors are grateful to Prof. Charles Greenough of James Cook University Hospital, Middlesborough, UK and Prof. Robert Fraser of The University of Adelaide, South Australia, Australia for allowing the use of the LBOS.

Our thanks are also extended to Tina Rogers and Teresa Grasso, who helped with the preparation of this manuscript and the compilation of this study's patient list.

This research was completed without grant support or any financial assistance.

Declaration of interest: The author reports no conflict of interest. The author alone is responsible for the content and writing of this paper.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.